Acute T Cell Leukemia
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Anti-TRBC1 CAR-T Cell Therapy in Patients With TRBC1 Positive T Cell Malignancies (NCT04828174) | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 2021-03-31 |
| Ruxolitinib Plus LVP in Patients With R/R ETP-ALL (NCT03613428) | Sichuan University | 2018-12-01 |
Track Acute T Cell Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.